正式报名：首届全球心血管大会 | 赠送纸质白皮书 合作伙伴征集：2025全球手术机器人大会 2025年4月28日，迈瑞医疗发布2024年年报以及2025年第一季度季报。2024年年度营业收入达到 367.3亿元 ，2025年第一季度营业收入达到 82.4亿 元。 公司预计2025年上下半年的收入将回归到 "前低后高" 的历史常态分布，并呈现出逐季度环比改善的趋势，其中营业收入同比增速将从三季度开始迎来重大 拐点。 # 2024年报数据 迈瑞医疗主要产品覆盖三大 业务 领域， 生命信息与支持、体外诊断以及医学 影像， 叠加"三瑞"智慧生态系统和垂域AI大模型，为医疗机构提供提升整体 诊疗能力的数智化方案。 生命信息与支持 报告期内，公司生命信息与支持业务实现营业收入约 135.57亿元 ，同比 减少11.11%， 其中微创外科业务同比增长超过30%，国际生命信息与支持业务实 现了同比双位数增长。 | | 2024 年 | 2023 年 | 本年比上年增减 | 2022 年 | | --- | --- | --- | --- | --- | | 营业收入(元) | 36,725,749,548.00 | 34,9 ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [7]. Core Views - The company demonstrated operational resilience through cycles and continues to explore new business opportunities [4]. - In 2024, the company achieved revenue of 168.31 billion yuan, with a year-on-year growth of 7%, and a net profit attributable to shareholders of 42.72 billion yuan, growing by 10% [2][4]. - The company reported a slight decline in gross margin, with Q4 2024 and Q1 2025 gross margins decreasing by 3.1 and 1.1 percentage points, respectively, primarily due to rising raw material prices [10]. Financial Performance Summary - For 2024, the company achieved revenue of 168.31 billion yuan, net profit of 42.72 billion yuan, and net profit after deducting non-recurring items of 37.42 billion yuan, with respective growth rates of 7%, 10%, and 1% [2][4]. - In Q4 2024, the company reported revenue of 42.27 billion yuan, net profit of 10.09 billion yuan, and net profit after deducting non-recurring items of 9.02 billion yuan, with year-on-year changes of +3%, -5%, and -16% [2][4]. - For Q1 2025, the company achieved revenue of 39.22 billion yuan, net profit of 9.75 billion yuan, and net profit after deducting non-recurring items of 8.55 billion yuan, with year-on-year growth of +3%, +5%, and +5% [2][4]. Business Segment Performance - Traditional business growth has slowed but remains above industry averages, with revenue growth of 3% in both Q4 2024 and Q1 2025 [10]. - The electrical connection business, smart electrical lighting, and new energy business saw year-on-year growth rates of +4.0%, +5.4%, and +104.7% in 2024, respectively [10]. - The company plans to focus on three strategic directions: smart ecology, new energy, and internationalization, with significant expansions in retail and operational capabilities [10]. Future Outlook - The company forecasts net profits of 46.0 billion yuan, 50.5 billion yuan, and 55.7 billion yuan for 2025, 2026, and 2027, respectively, with corresponding price-to-earnings ratios of 20, 18, and 17 [10]. - The dividend payout ratio for 2024 is projected to be 72.6%, with a dividend yield of 3.3% [10].

Financial Data and Key Metrics Changes - In Q1 2025, total revenue reached $6.554 billion, a 6% increase year over year [3] - EBITDA was $786 million, reflecting a 16.6% increase compared to the previous year [3] - Operating profit stood at $598 million, up 19.4% year over year [3] - Profit attributable to owners was $364 million, a 20.9% increase from last year [3] - Basic earnings per share were $2.84, also a 20.9% increase year over year [3] Business Line Data and Key Metrics Changes - Packaged meats accounted for 49.5% of total revenue and 83.8% of operating profit in Q1 2025 [4] - The pork business contributed 42.9% of revenue and 21.9% of operating profit [4] - Other businesses contributed 7.6% of revenue but incurred a loss of $34 million [4] - In North America, operating profits increased by 72.8% to $330 million [9] - In China, operating profit was $250 million, down 14.3% year over year [8] Market Data and Key Metrics Changes - In China, the average hog price was RMB 15.99 per kilogram, up 7.3% year over year [6] - In the U.S., the average hog price was $1.44 per kilogram, up 14.1% year over year [6] - In Europe, the average hog price was $1.40 per kilogram, down 11.8% year over year [7] - The number of slaughter hogs in China increased by 0.1% year over year to 195 million heads [6] Company Strategy and Development Direction - The company aims to consolidate global resources, improve product mix, adjust pricing, and control costs [10] - Key business priorities include improving the pork business, expanding market networks, and optimizing the business portfolio [11] - The focus remains on industrialization, diversification, internalization, and digitalization to enhance market position [10] Management Comments on Operating Environment and Future Outlook - Management noted that consumer demand remains soft, impacting the packaged meat business [12] - The company is implementing eight measures to return the packaged meat business to growth, including specialized sales forces and enhanced marketing efforts [14][16] - Management expects the second quarter to show recovery in packaged meat volume and profit [16] Other Important Information - The hog production business is seen as a supporting business rather than a core focus, with strategies tailored to local market conditions [42][43] - The company plans to maintain a vertical integration level of 20% to 30% in hog production, focusing on fresh pork and packaged meat as core businesses [65] Q&A Session Summary Question: Reasons for decline in China packaged meat business - Management cited soft consumer demand, destocking by distributors, and slow adaptation to market channel changes as key reasons [12][13] Question: Outlook for packaged meat business in Q2 2025 - Management expects the packaged meat business to stop declining and gradually recover in Q2, with full-year growth anticipated [16] Question: Impact of tariffs on hog prices - Management believes tariffs will have limited short-term impact on hog prices, with supply and demand balance being the primary driver [34][35] Question: Hog production improvement drivers - The improvement in hog production is driven by reduced raising costs and improved KPIs rather than hog prices [21] Question: U.S. pork business outlook - Management expects profitability in the U.S. pork business to improve in Q2 and Q3, aligning with seasonal trends [67]

Financial Data and Key Metrics Changes - In Q1 2025, total revenue was $6.554 billion, a 6% increase year-over-year [3] - EBITDA reached $786 million, up 16.6% from the previous year [3] - Operating profit was $598 million, reflecting a 19.4% increase year-over-year [3] - Profit attributable to owners was $364 million, a 20.9% increase compared to last year [3] - Basic earnings per share rose to $2.84, marking a 20.9% increase year-over-year [3] Business Line Data and Key Metrics Changes - Packaged meats accounted for 49.5% of total revenue and 83.8% of operating profit [4] - Pork business contributed 42.9% of revenue and 21.9% of operating profit [4] - Other businesses contributed 7.6% of revenue but incurred a loss of $34 million [4] - In North America, operating profits increased by 72.8% to $330 million [8] - In China, operating profit was $250 million, down 14.3% year-over-year [8] Market Data and Key Metrics Changes - In China, the average hog price was RMB 15.99 per kilogram, up 7.3% year-over-year [6] - In the U.S., the average hog price was $1.44 per kilogram, up 14.1% year-over-year [6] - In Europe, the average hog price was $1.40 per kilogram, down 11.8% year-over-year [7] - The number of slaughter hogs in China increased by 0.1% year-over-year to 195 million heads [6] Company Strategy and Development Direction - The company aims to consolidate global resources, enhance market competitiveness, and focus on industrialization, diversification, internalization, and digitalization [10] - Priorities include improving the pork business, expanding the market network, and optimizing the business portfolio [10][11] - The company plans to adapt to market changes and strengthen competitive edges to drive steady improvements in sales volume and results [10] Management Comments on Operating Environment and Future Outlook - Management noted that consumer demand remains soft, impacting the packaged meat business [12] - The company is implementing eight measures to return the packaged meat business to growth, including specialized sales forces and increased marketing investments [14][16] - Management expects the packaged meat business to stabilize in the second quarter and grow in the second half of 2025 [16] - The hog production business is expected to improve significantly in 2025, driven by reduced raising costs and improved KPIs [21] Other Important Information - The company anticipates that the profit per ton for packaged meats will be lower than last year but will remain at a relatively high level [17] - The hog production business in China is expected to see significant improvements, with a projected profit increase of around RMB 500 million year-over-year [21] - The company is focusing on maintaining a strong position in the global pork industry while tailoring strategies based on local market conditions [43][44] Q&A Session Summary Question: What are the reasons for the decline in the packaged meat business in Q1? - Management cited soft consumer demand, destocking by distributors, and slow adaptation to market channel changes as key reasons [12][13] Question: What measures are being taken to return the packaged meat business to growth? - Eight measures were outlined, including specialized sales forces, expanding the point of sales, and increased marketing investments [14][16] Question: What is the outlook for hog prices and production in China? - Management expects hog prices to be lower than last year, but improvements in hog production are anticipated due to reduced raising costs [20][21] Question: How will tariffs impact the hog production business? - Tariffs are expected to have limited short-term impact on hog prices, but may affect raising costs in the long term [35][56] Question: What is the expected contribution of different product categories in the packaged meat business? - Frozen and snack products are expected to grow faster, with contributions increasing from around 5% to 8% by the end of the year [62]

Core Viewpoint - The company reported a significant decline in revenue and net profit for 2024, with a focus on improving profitability and advancing its new energy strategy while maintaining its leading position in the commercial vehicle market [1][2][3]. Financial Performance - In 2024, the company achieved revenue of 47.7 billion yuan, a year-on-year decrease of 15.0%, and a net profit attributable to shareholders of 0.08 billion yuan, down 91.1% year-on-year [1]. - For Q4 2024, revenue was 11.94 billion yuan, a decrease of 9.3% year-on-year but an increase of 1.2% quarter-on-quarter; the net profit attributable to shareholders was -0.35 billion yuan, a decline of 391.2% year-on-year and 2052.2% quarter-on-quarter [1][2]. - The gross margin for 2024 was 12.6%, up 1.3 percentage points year-on-year, while the net profit margin was 0.2%, down 1.5 percentage points year-on-year [2]. Market Position and Strategy - The company maintained its leading position in the commercial vehicle sector, achieving total sales of 614,000 units in 2024, a decrease of 2.7% year-on-year, with a market share of 15.9%, up 0.2 percentage points [3]. - New energy vehicle sales reached 54,000 units, a growth of 35% year-on-year, with a market share increase of 0.4 percentage points [3]. - The company is advancing its new energy strategy, focusing on the development of core technologies and products, including the launch of various new energy models across different market segments [3]. International Expansion - In 2024, the company exported 153,000 vehicles, a year-on-year increase of 17.3%, maintaining a market share of 17% in the commercial vehicle export sector [4]. - The company has made significant progress in international markets, particularly in the Americas and Southeast Asia, and has achieved breakthroughs in high-end markets such as Europe and Japan [4]. - The company is implementing a dual-brand strategy for overseas markets, optimizing its management structure to support its heavy-duty truck business [4].

Financial Performance - In 2024, the company achieved total revenue of 36.726 billion CNY, a year-on-year increase of 5.14% [2] - The net profit attributable to shareholders was 11.668 billion CNY, up 0.74% year-on-year; excluding financial expenses, the net profit growth was 4.36% [2] - Operating cash flow reached 12.432 billion CNY, reflecting a year-on-year increase of 12.38% [2] - For Q1 2025, total revenue was 8.237 billion CNY, a decline of 12.12% compared to the same period last year, with net profit down 16.81% [9] Dividend Distribution - The company plans to distribute 679 million CNY (including tax) as dividends for 2024, with a cumulative cash dividend of 7.602 billion CNY, representing a payout ratio of 65.15% [3] - A proposal for a mid-year dividend of 1.71 billion CNY (including tax) for 2025 is also in place, pending shareholder approval [3] Market Performance International Market - The international market grew by 21.28% in 2024, with the Asia-Pacific region seeing nearly 40% growth driven by countries like Australia, Thailand, and India [4] - International revenue accounted for approximately 45% of total revenue, with high-potential segments like minimally invasive surgery and cardiovascular care nearing 10% of international income [4] Domestic Market - The domestic market experienced a decline of 5.10% due to sluggish hospital equipment procurement and the impact of DRG 2.0 [4] - A recovery is anticipated in Q3 2025 as local fiscal pressures ease and medical equipment projects are initiated [4] Product Line Performance In Vitro Diagnostics (IVD) - The IVD segment grew by 10.82% in 2024, with international IVD growth exceeding 30% [5] - IVD revenue now constitutes 37.48% of total company revenue, surpassing the life information and support segment [5] Medical Imaging - The medical imaging segment grew by 6.60%, with international growth over 15% [7] - The launch of the high-end Resona A20 ultrasound is expected to enhance market presence [7] Life Information and Support - This segment saw a decline of 11.11%, although international growth was in double digits [8] - The company maintains a leading market share in domestic monitoring and respiratory devices despite challenges [8] Research and Development - R&D investment for 2024 was 4.008 billion CNY, accounting for 10.91% of revenue, while Q1 2025 saw 847 million CNY in R&D, representing 10.28% of revenue [11] - New product launches include advanced systems in life information and support, IVD, and medical imaging [12][13] Sustainability Efforts - The company received an AA rating from MSCI ESG and was included in the S&P Global Sustainable Development Yearbook [14] - Carbon emissions intensity decreased by 11.6% compared to 2021, with ongoing projects contributing to sustainability goals [15] Future Outlook - The company anticipates a significant recovery in domestic revenue starting Q3 2025, driven by the resumption of medical equipment projects [10] - Long-term growth strategies focus on digitalization, internationalization, and enhancing the supply chain to adapt to changing market conditions [24][25]

Core Insights - The article highlights the rise of Chinese beauty brands, with Proya Cosmetics becoming the first company in the industry to exceed 10 billion yuan in revenue, aiming to rank among the top ten global cosmetics companies in the next decade [1][6]. Group 1: Company Overview - Proya Cosmetics has established three major R&D centers to create an international research and development framework, focusing on product safety and quality through rigorous testing processes [3][5]. - The company has been a leader in the Chinese beauty industry for two consecutive years, driven by technological innovation, and has set national standards and obtained numerous patents [6][9]. Group 2: R&D and Innovation - Proya's R&D efforts have led to the development of the "Optical 335" ingredient, a patented dual-degradable whitening formula, showcasing the company's commitment to innovative product development [7][8]. - The company has increased its R&D personnel by 20.81% year-on-year, with a significant proportion holding advanced degrees, reflecting its focus on building a diverse and skilled innovation team [9]. Group 3: Global Strategy - Proya aims to enhance its global presence by establishing an R&D center in Paris, which will serve as an international laboratory to attract top talent and integrate advanced technologies [12]. - The company emphasizes the importance of aligning its technological capabilities and product strength to compete with established international brands in the global beauty market [9][12].

Group 1 - Chery Group showcased 53 models from its five brands, including Chery, Exeed, Jetour, iCAR, and Zhijie, at the 2025 Shanghai International Auto Show [1][3] - The new Chery QQ targets the A0 electric vehicle market, featuring a classic design and a user co-creation plan set for May [3][5] - The Fengyun A9, a C-class sedan, has received over 53,565 orders in 35 days since its blind booking, with a limited release of 5,000 founder editions [5][7] Group 2 - In Q1 2023, Chery Group achieved a record sales volume of 620,000 vehicles, with 255,000 units exported, maintaining the top position among Chinese automakers in exports [9] - Chery's chairman emphasized the company's commitment to "four modernizations": electrification, intelligence, low carbon, and internationalization, with a record 5,000 overseas guests at the auto show [9] - Chery introduced its "Land, Sea, and Air" technology system, showcasing products like the Kunpeng super hybrid system and amphibious vehicles [9]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has received approval for new products, which are expected to gradually increase in volume, driving growth through internationalization and innovation [1] - In 2024, the company achieved a total revenue of 1.35 billion yuan, representing a year-on-year increase of 20.82%, and a net profit attributable to shareholders of 238.23 million yuan, up 5.15% year-on-year [7] - The company is focusing on the anesthesia and analgesia sector, with significant investments in research and development, which accounted for 21.31% of revenue in 2024 [7] Financial Performance Summary - Total revenue projections for the company are as follows: 1.35 billion yuan in 2024, 1.59 billion yuan in 2025, 1.90 billion yuan in 2026, and 2.26 billion yuan in 2027, with respective year-on-year growth rates of 20.82%, 18.02%, 18.98%, and 19.31% [1][8] - The net profit attributable to shareholders is projected to be 238.23 million yuan in 2024, 281.30 million yuan in 2025, 335.30 million yuan in 2026, and 400.75 million yuan in 2027, with year-on-year growth rates of 5.15%, 18.08%, 19.20%, and 19.52% respectively [1][8] - The company’s earnings per share (EPS) are expected to be 1.35 yuan in 2024, 1.59 yuan in 2025, 1.90 yuan in 2026, and 2.27 yuan in 2027 [1][8] Business Segment Performance - The chemical formulation segment generated revenue of 1.077 billion yuan in 2024, up 22.25% year-on-year, while the raw materials segment saw revenue of 121 million yuan, an increase of 28.65% [7] - The CMO/CDMO business experienced significant growth, with revenue reaching 65 million yuan, a remarkable increase of 111.59% [7] - The company has successfully launched 16 anesthesia and analgesia products and has over 20 products in development, indicating a strong competitive position in the market [7]

Core Viewpoint - The company reported a stable performance in 2024 with revenue of 16.486 billion yuan, a year-on-year increase of 1.15%, and a net profit of 2.022 billion yuan, up 17.86% [1]. Group 1: Financial Performance - In Q1 2025, the company achieved revenue of 4.506 billion yuan, a year-on-year increase of 8.02%, and a net profit of 436 million yuan, up 15.18%, meeting market expectations [1]. - The gross margin and net margin for 2024 improved by 2.77 and 1.84 percentage points to 23.55% and 13.11%, respectively [1]. - Operating cash flow declined, potentially due to longer account periods for overseas sales and an increased proportion of leasing business [1]. Group 2: Product and Market Development - The total sales of lithium battery forklifts reached 448,800 units in 2024, with the proportion of electric forklifts rising to 47.43% [1]. - The company launched several high-performance lithium battery forklifts, covering a weight range from 0.6t to 48t, continuously optimizing product structure and series [1]. - In 2024, overseas product sales exceeded 100,000 units, marking a historical high, with overseas revenue accounting for over 40% [2]. Group 3: International Expansion and Future Outlook - The company has established over 10 overseas sales companies and service centers across major regions, forming a three-tier service network covering over 200 countries [2]. - Despite trade risks in the North American market, there remains significant growth potential in Europe, Southeast Asia, and Oceania [2]. - The company is expected to achieve net profits of 2.3 billion, 2.5 billion, and 2.8 billion yuan from 2025 to 2027, with corresponding PE ratios of 11, 10, and 9 times, maintaining a "recommended" rating [2].